{
  "links": "https://www.ycombinator.com/companies/nearwave",
  "name": "NearWave",
  "headline": "Helping physicians select the right therapy for breast cancer patients",
  "batch": "W22",
  "description": "NearWave makes a handheld imaging device that helps physicians select the right therapy for their breast cancer patients. This prevents patients from suffering through months of side effects caused by unsuccessful treatments.",
  "activity_status": "Active",
  "website": "http://nearwave.co",
  "founded_date": 2022.0,
  "team_size": 3.0,
  "location": "Austin, TX",
  "group_partner": null,
  "group_partner_yc": null,
  "company_linkedin": null,
  "company_twitter": null,
  "tags": "industry:artificial-intelligence; industry:hard-tech; industry:hardware; industry:saas; industry:medical-devices; location:austin",
  "founders": [
    {
      "name": "Dr. Roy Stillwell, PhD, Founder",
      "description": "Roy Stillwell is the co-founder, CEO and chief engineer of NearWave, which he co-founded with Professor Thomas O'Sullivan in 2020. He has a PhD in electrical engineering, with a focus in biophotonics research. Originally from Colorado, Roy is a father, husband, technologist, gamer, boarder, and loves to build.",
      "linkedin": "https://www.linkedin.com/in/roy-stillwell-12448916/"
    }
  ],
  "status": true,
  "markdown": "raw_markdown=\"[Skip to content](http://nearwave.co/<#main>)\\n[ Get Info ](http://nearwave.co/</company/buy-now/>)\\n  * [Technology](http://nearwave.co/<https:/nearwave.co/technology/>)\\n    * [fdNIRS](http://nearwave.co/<https:/nearwave.co/technology/fdnirs/>)\\n    * [Our Device](http://nearwave.co/<https:/nearwave.co/technology/our-device/>)\\n    * [Publications](http://nearwave.co/<https:/nearwave.co/technology/publications/>)\\n    * [Investigational Studies](http://nearwave.co/<https:/nearwave.co/technology/clinical-and-research-applications/>)\\n  * [Company](http://nearwave.co/<https:/nearwave.co/company/>)\\n    * [Investors](http://nearwave.co/<https:/nearwave.co/company/investors/>)\\n    * [News](http://nearwave.co/<https:/nearwave.co/company/news/>)\\n    * [Contact Us](http://nearwave.co/<https:/nearwave.co/company/contact/>)\\n  * [About Us](http://nearwave.co/<https:/nearwave.co/about/>)\\n  * [Newsletter](http://nearwave.co/<https:/nearwave.co/newsletter/>)\\n  * [Nearwave – Safe tissue scanning with near infrared light](http://nearwave.co/<https:/nearwave.co/>)\\n\\n\\n[![NearWave](https://nearwave.co/wp-content/uploads/2021/04/logo_dark.png)](http://nearwave.co/<https:/nearwave.co/>)\\n  * [Technology](http://nearwave.co/<https:/nearwave.co/technology/>)\\n    * [fdNIRS](http://nearwave.co/<https:/nearwave.co/technology/fdnirs/>)\\n    * [Our Device](http://nearwave.co/<https:/nearwave.co/technology/our-device/>)\\n    * [Publications](http://nearwave.co/<https:/nearwave.co/technology/publications/>)\\n    * [Investigational Studies](http://nearwave.co/<https:/nearwave.co/technology/clinical-and-research-applications/>)\\n  * [Company](http://nearwave.co/<https:/nearwave.co/company/>)\\n    * [Investors](http://nearwave.co/<https:/nearwave.co/company/investors/>)\\n    * [News](http://nearwave.co/<https:/nearwave.co/company/news/>)\\n    * [Contact Us](http://nearwave.co/<https:/nearwave.co/company/contact/>)\\n  * [About Us](http://nearwave.co/<https:/nearwave.co/about/>)\\n  * [Newsletter](http://nearwave.co/<https:/nearwave.co/newsletter/>)\\n  * [Nearwave – Safe tissue scanning with near infrared light](http://nearwave.co/<https:/nearwave.co/>)\\n\\n\\n[ Get Info ](http://nearwave.co/</company/buy-now/>)\\n[![NearWave](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20401%2044'%3E%3C/svg%3E)](http://nearwave.co/<https:/nearwave.co/>)\\nThe Future Is \\nNear Infrared\\nA breakthrough, safe, non-invasive device using fdNIRS to assess vital biomarkers, including tissue oxygen saturation and concentrations of hemoglobin.\\n![](https://nearwave.co/wp-content/uploads/2023/11/straighton_editeddevice-1.png)\\nIntroducing \\nThe NearWave Scanner\\nNon-Invasive.\\nNon-Ionizing.\\nDeep Tissue.\\nQuantitative.\\n[Technical Info](http://nearwave.co/<our-device>)\\nNotice: Investigational device. The NearWave Scanner® is currently used for research only.\\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20585%20813'%3E%3C/svg%3E)\\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20639%20532'%3E%3C/svg%3E)\\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20639%20534'%3E%3C/svg%3E)\\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20641%20534'%3E%3C/svg%3E)\\nSmallest, fastest, easiest to use frequency domain near infrared spectroscopy (fdNIRS) device in the world\\nExperience a culmination of 30 years of diffuse optics science in a single device. The NearWave Scanner is the smallest fully integrated, battery powered handheld, fastest (36.6kHz for high speed mapping), and easiest to use fdNIRS based device in the world. From the clinic to the research lab, the iOS companion app allows for real-time visual display of 1D and 2D quantitative mapping data.\\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201170%20796'%3E%3C/svg%3E)\\n# What is Frequency Domain Near Infrared Spectroscopy (fdNIRS)?\\nIn clinical applications, fdNIRS is used to measure optical properties such as absorption and scattering in deep tissue (1-2.5cm). The resulting information can lead to quantitative metabolic measurements of key biomarkers in the tissue such as regional oxygen saturation and hemoglobin concentrations. This provides clinicians with greater insight, facilitating the development of predictive models for clinical diagnostic information. \\n[LEARN MORE](http://nearwave.co/<https:/nearwave.co/technology/fdnirs/>)\\n**Applications of fdNIRS**\\n#  Tissue Oximetry\\n![Image by Arek Socha from Pixabay](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20533%20354'%3E%3C/svg%3E)\\n## Measure Tissue Oxygenation \\n## Including StO2, HHb (or Hbr), HbO2, and THb\\nfdNIRS can provide quantitative tissue perfusion information including StO2, HHb (or Hbr), HbO2, and THb. This information can be used in many clinical applications ranging from sports medicine and weight loss to cardiovascular health assessment and treatment.\\n[LEARN MORE](http://nearwave.co/<clinical-and-research-applications#to>)\\nNotice: The NearWave Scanner is currently intended for investigational use only. \\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20374%2088'%3E%3C/svg%3E)\\n#### We are working with a number of universities and hospitals around the country.\\n[Meet Our Partners](http://nearwave.co/<https:/osullivangroup.nd.edu/>)\\nCopyright © 2025 NearWave\\n[ Facebook ](http://nearwave.co/<https:/www.facebook.com/nearwave/>) [ X (Twitter) ](http://nearwave.co/<https:/twitter.com/NearWave/>) [ Instagram ](http://nearwave.co/<https:/www.instagram.com/nearwave/>) [ LinkedIn ](http://nearwave.co/<https:/www.linkedin.com/company/nearwave/about/>)\\nNotifications\\n\" markdown_with_citations=\"Skip to content⟨1⟩\\n Get Info ⟨2⟩\\n  * Technology⟨3⟩\\n    * fdNIRS⟨4⟩\\n    * Our Device⟨5⟩\\n    * Publications⟨6⟩\\n    * Investigational Studies⟨7⟩\\n  * Company⟨8⟩\\n    * Investors⟨9⟩\\n    * News⟨10⟩\\n    * Contact Us⟨11⟩\\n  * About Us⟨12⟩\\n  * Newsletter⟨13⟩\\n  * Nearwave – Safe tissue scanning with near infrared light⟨14⟩\\n\\n\\n![NearWave⟨15⟩](http://nearwave.co/<https:/nearwave.co/>)\\n  * Technology⟨3⟩\\n    * fdNIRS⟨4⟩\\n    * Our Device⟨5⟩\\n    * Publications⟨6⟩\\n    * Investigational Studies⟨7⟩\\n  * Company⟨8⟩\\n    * Investors⟨9⟩\\n    * News⟨10⟩\\n    * Contact Us⟨11⟩\\n  * About Us⟨12⟩\\n  * Newsletter⟨13⟩\\n  * Nearwave – Safe tissue scanning with near infrared light⟨14⟩\\n\\n\\n Get Info ⟨2⟩\\n![NearWave⟨16⟩](http://nearwave.co/<https:/nearwave.co/>)\\nThe Future Is \\nNear Infrared\\nA breakthrough, safe, non-invasive device using fdNIRS to assess vital biomarkers, including tissue oxygen saturation and concentrations of hemoglobin.\\n![](https://nearwave.co/wp-content/uploads/2023/11/straighton_editeddevice-1.png)\\nIntroducing \\nThe NearWave Scanner\\nNon-Invasive.\\nNon-Ionizing.\\nDeep Tissue.\\nQuantitative.\\nTechnical Info⟨17⟩\\nNotice: Investigational device. The NearWave Scanner® is currently used for research only.\\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20585%20813'%3E%3C/svg%3E)\\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20639%20532'%3E%3C/svg%3E)\\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20639%20534'%3E%3C/svg%3E)\\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20641%20534'%3E%3C/svg%3E)\\nSmallest, fastest, easiest to use frequency domain near infrared spectroscopy (fdNIRS) device in the world\\nExperience a culmination of 30 years of diffuse optics science in a single device. The NearWave Scanner is the smallest fully integrated, battery powered handheld, fastest (36.6kHz for high speed mapping), and easiest to use fdNIRS based device in the world. From the clinic to the research lab, the iOS companion app allows for real-time visual display of 1D and 2D quantitative mapping data.\\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201170%20796'%3E%3C/svg%3E)\\n# What is Frequency Domain Near Infrared Spectroscopy (fdNIRS)?\\nIn clinical applications, fdNIRS is used to measure optical properties such as absorption and scattering in deep tissue (1-2.5cm). The resulting information can lead to quantitative metabolic measurements of key biomarkers in the tissue such as regional oxygen saturation and hemoglobin concentrations. This provides clinicians with greater insight, facilitating the development of predictive models for clinical diagnostic information. \\nLEARN MORE⟨4⟩\\n**Applications of fdNIRS**\\n#  Tissue Oximetry\\n![Image by Arek Socha from Pixabay⟨18⟩]\\n## Measure Tissue Oxygenation \\n## Including StO2, HHb (or Hbr), HbO2, and THb\\nfdNIRS can provide quantitative tissue perfusion information including StO2, HHb (or Hbr), HbO2, and THb. This information can be used in many clinical applications ranging from sports medicine and weight loss to cardiovascular health assessment and treatment.\\nLEARN MORE⟨19⟩\\nNotice: The NearWave Scanner is currently intended for investigational use only. \\n![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20374%2088'%3E%3C/svg%3E)\\n#### We are working with a number of universities and hospitals around the country.\\nMeet Our Partners⟨20⟩\\nCopyright © 2025 NearWave\\n Facebook ⟨21⟩  X (Twitter) ⟨22⟩  Instagram ⟨23⟩  LinkedIn ⟨24⟩\\nNotifications\\n\" references_markdown=\"\\n\\n## References\\n\\n⟨1⟩ http://nearwave.co/<#main>: Skip to content\\n⟨2⟩ http://nearwave.co/</company/buy-now/>:  Get Info \\n⟨3⟩ http://nearwave.co/<https:/nearwave.co/technology/>: Technology\\n⟨4⟩ http://nearwave.co/<https:/nearwave.co/technology/fdnirs/>: fdNIRS\\n⟨5⟩ http://nearwave.co/<https:/nearwave.co/technology/our-device/>: Our Device\\n⟨6⟩ http://nearwave.co/<https:/nearwave.co/technology/publications/>: Publications\\n⟨7⟩ http://nearwave.co/<https:/nearwave.co/technology/clinical-and-research-applications/>: Investigational Studies\\n⟨8⟩ http://nearwave.co/<https:/nearwave.co/company/>: Company\\n⟨9⟩ http://nearwave.co/<https:/nearwave.co/company/investors/>: Investors\\n⟨10⟩ http://nearwave.co/<https:/nearwave.co/company/news/>: News\\n⟨11⟩ http://nearwave.co/<https:/nearwave.co/company/contact/>: Contact Us\\n⟨12⟩ http://nearwave.co/<https:/nearwave.co/about/>: About Us\\n⟨13⟩ http://nearwave.co/<https:/nearwave.co/newsletter/>: Newsletter\\n⟨14⟩ http://nearwave.co/<https:/nearwave.co/>: Nearwave – Safe tissue scanning with near infrared light\\n⟨15⟩ https://nearwave.co/wp-content/uploads/2021/04/logo_dark.png: ![NearWave\\n⟨16⟩ data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20401%2044'%3E%3C/svg%3E: ![NearWave\\n⟨17⟩ http://nearwave.co/<our-device>: Technical Info\\n⟨18⟩ data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20533%20354'%3E%3C/svg%3E: Image by Arek Socha from Pixabay\\n⟨19⟩ http://nearwave.co/<clinical-and-research-applications#to>: LEARN MORE\\n⟨20⟩ http://nearwave.co/<https:/osullivangroup.nd.edu/>: Meet Our Partners\\n⟨21⟩ http://nearwave.co/<https:/www.facebook.com/nearwave/>:  Facebook \\n⟨22⟩ http://nearwave.co/<https:/twitter.com/NearWave/>:  X (Twitter) \\n⟨23⟩ http://nearwave.co/<https:/www.instagram.com/nearwave/>:  Instagram \\n⟨24⟩ http://nearwave.co/<https:/www.linkedin.com/company/nearwave/about/>:  LinkedIn \\n\" fit_markdown='' fit_html=''",
  "generated_description": "**NearWave: Revolutionizing Breast Cancer Treatment**\n\nFounded in 2022 and hailing from the vibrant tech hub of Austin, TX, NearWave aims to transform the way physicians approach breast cancer therapies. At its core, the company has developed a groundbreaking handheld imaging device specifically designed to help doctors determine the most effective treatments for breast cancer patients. This innovation can potentially spare patients from the grueling experience of ineffective therapies and their associated side effects.\n\nNearWave’s mission is clear: assist healthcare providers in selecting the right therapies at the right time, ultimately improving the quality of care for those facing a challenging diagnosis. The company is a proud participant of Y Combinator Batch W22, gathering traction and support in the startup ecosystem.\n\nThe heart of NearWave’s technology is its Frequency Domain Near Infrared Spectroscopy (fdNIRS). This non-invasive approach allows for detailed measurements of key tissue biomarkers, such as oxygen saturation and hemoglobin levels—critical factors in assessing the best treatment modalities. The NearWave Scanner stands out as the world's smallest, most efficient fdNIRS device, integrating over 30 years of diffuse optics science into a user-friendly format.\n\nWith a dedicated team of just three, NearWave is taking strategic steps to forge partnerships with universities and hospitals nationwide, leveraging their technology in clinical settings. The website, [NearWave.co](http://nearwave.co), serves as a hub for technology insights, company updates, and research applications, inviting potential collaborators and clients to engage with their mission. \n\nIf you’re interested in the intersection of health and technology, or simply want to learn more about how NearWave is changing lives through innovation, be sure to check them out. The future of breast cancer treatment may be closer than we think."
}